Fortis Capital Management LLC

Position in JNJ — Johnson & Johnson

CIK 1802167 BELLEVUE, WA

Position in JNJ

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,730,043

+$183,716 QoQ

Shares Held

6,812

+7.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#2,473

of 4,664 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fortis Capital Management LLC holds $16,796,483 across 6 Drug Manufacturers - General names. JNJ ranks #3 (10.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	9,311	$11,167,893
2	ABBV	AbbVie Inc.	8,042	$2,023,688
3	JNJ	Johnson & Johnson This page	6,812	$1,730,043
4	AMGN	Amgen Inc	3,739	$1,353,966
5	NVS	Novartis AG	1,665	$260,938
6	MRK	Merck & Co., Inc.	2,023	$259,955

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,730,043	6,812	+7.7%	Shares	Sole	2026-08-13
2026-03-31	$1,546,327	6,326	+10.5%	Shares	Sole	2026-05-12
2025-12-31	$1,185,202	5,727	+5.1%	Shares	Sole	2026-02-13
2025-09-30	$1,010,353	5,449	+3.7%	Shares	Sole	2025-11-10
2025-06-30	$803,006	5,257	+13.5%	Shares	Sole	2025-08-12
2025-03-31	$767,839	4,630	—	Shares	Sole	2025-05-09
No filing history on record for this holder in this stock.